OR8B8
gene geneOn this page
Also known as TPCR85
Summary
OR8B8 (olfactory receptor family 8 subfamily B member 8, HGNC:8477) is a protein-coding gene on chromosome 11q24.2, encoding Olfactory receptor 8B8 (Q15620). Odorant receptor (Potential).
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 26493 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 42 total
- MANE Select transcript:
NM_012378
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:8477 |
| Approved symbol | OR8B8 |
| Name | olfactory receptor family 8 subfamily B member 8 |
| Location | 11q24.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | TPCR85 |
| Ensembl gene | ENSG00000197125 |
| Ensembl biotype | protein_coding |
| Entrez | 26493 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000328064, ENST00000642064
RefSeq mRNA: 1 — MANE Select: NM_012378
NM_012378
CCDS: CCDS8446
Canonical transcript exons
ENST00000642064 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003812041 | 124445576 | 124445696 |
| ENSE00003814027 | 124437445 | 124441101 |
| ENSE00003814212 | 124441488 | 124441623 |
Expression profiles
Bgee: expression breadth tissue_specific, 2 present calls, max score 52.89.
Top tissues by expression
240 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| buccal mucosa cell | CL:0002336 | 52.89 | gold quality |
| skin of hip | UBERON:0001554 | 49.87 | silver quality |
| vastus lateralis | UBERON:0001379 | 46.72 | gold quality |
| quadriceps femoris | UBERON:0001377 | 46.56 | gold quality |
| sural nerve | UBERON:0015488 | 46.19 | gold quality |
| upper leg skin | UBERON:0004262 | 43.71 | silver quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| superficial temporal artery | UBERON:0001614 | 41.33 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 41.10 | gold quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 41.06 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 40.98 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 40.74 | gold quality |
| amniotic fluid | UBERON:0000173 | 40.69 | gold quality |
| jejunal mucosa | UBERON:0000399 | 40.59 | gold quality |
| biceps brachii | UBERON:0001507 | 40.57 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 40.45 | gold quality |
| myocardium | UBERON:0002349 | 40.45 | gold quality |
| gingival epithelium | UBERON:0001949 | 40.43 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 40.33 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 40.29 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 40.27 | gold quality |
| jejunum | UBERON:0002115 | 40.18 | gold quality |
| cartilage tissue | UBERON:0002418 | 40.06 | gold quality |
| oviduct epithelium | UBERON:0004804 | 40.03 | gold quality |
| mammary duct | UBERON:0001765 | 39.98 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 39.95 | gold quality |
| deltoid | UBERON:0001476 | 39.83 | gold quality |
| saphenous vein | UBERON:0007318 | 39.83 | gold quality |
| parotid gland | UBERON:0001831 | 39.81 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.44 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Or8b8 | ENSMUSG00000066748 |
| rattus_norvegicus | Or8b8 | ENSRNOG00000083397 |
Paralogs (96): OR5C1 (ENSG00000148215), OR5F1 (ENSG00000149133), OR8K1 (ENSG00000150261), OR5M9 (ENSG00000150269), OR14K1 (ENSG00000153230), OR8J3 (ENSG00000167822), OR5I1 (ENSG00000167825), OR5AU1 (ENSG00000169327), OR9K2 (ENSG00000170605), OR8B12 (ENSG00000170953), OR10H3 (ENSG00000171936), OR8I2 (ENSG00000172154), OR8U1 (ENSG00000172199), OR10V1 (ENSG00000172289), OR5A1 (ENSG00000172320), OR5A2 (ENSG00000172324), OR5B12 (ENSG00000172362), OR5B2 (ENSG00000172365), OR9I1 (ENSG00000172377), OR9G4 (ENSG00000172457), OR5AR1 (ENSG00000172459), OR5AP2 (ENSG00000172464), OR8J1 (ENSG00000172487), OR5B3 (ENSG00000172769), OR10W1 (ENSG00000172772), OR5M3 (ENSG00000174937), OR5J2 (ENSG00000174957), OR10H4 (ENSG00000176231), OR5AN1 (ENSG00000176495), OR14C36 (ENSG00000177174), OR6B3 (ENSG00000178586), OR10Q1 (ENSG00000180475), OR8G2P (ENSG00000181214), OR5AK2 (ENSG00000181273), OR5AK3P (ENSG00000181282), OR5M8 (ENSG00000181371), OR8D4 (ENSG00000181518), OR8H1 (ENSG00000181693), OR8K5 (ENSG00000181752), OR8H3 (ENSG00000181761)
Protein
Protein identifiers
Olfactory receptor 8B8 — Q15620 (reviewed: Q15620)
Alternative names: Olfactory receptor TPCR85, Olfactory-like receptor JCG8
All UniProt accessions (2): A0A126GW73, Q15620
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor (Potential). May be involved in taste perception.
Subcellular location. Cell membrane.
Tissue specificity. Expressed in the tongue and testis.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_036510* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
Pfam: PF13853
UniProt features (19 total): topological domain 8, transmembrane region 7, chain 1, glycosylation site 1, disulfide bond 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q15620-F1 | 90.05 | 0.74 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 97–189
Glycosylation sites (1): 5
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 31 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, chr11q24, GOMF_ODORANT_BINDING, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, TGACAGNY_MEIS1_01, WP_GPCRS_CLASS_A_RHODOPSINLIKE, REACTOME_OLFACTORY_SIGNALING_PATHWAY
GO Biological Process (4): G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608), signal transduction (GO:0007165), detection of chemical stimulus involved in sensory perception of smell (GO:0050911)
GO Molecular Function (3): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984), odorant binding (GO:0005549)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| binding | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
188 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR8B8 | CCDC198 | Q9NVL8 | 488 |
| OR8B8 | ZNF425 | Q6IV72 | 448 |
| OR8B8 | HDDC2 | Q7Z4H3 | 435 |
| OR8B8 | ZNF781 | Q8N8C0 | 419 |
| OR8B8 | SLC35F4 | A4IF30 | 419 |
| OR8B8 | CALHM3 | Q86XJ0 | 374 |
| OR8B8 | PCED1B | Q96HM7 | 371 |
| OR8B8 | OR7G1 | Q8NGA0 | 365 |
| OR8B8 | MTMR12 | Q9C0I1 | 359 |
| OR8B8 | ZNF699 | Q32M78 | 350 |
| OR8B8 | JADE2 | Q9NQC1 | 345 |
| OR8B8 | OR4D6 | Q8NGJ1 | 325 |
| OR8B8 | NPBWR2 | P48146 | 316 |
| OR8B8 | RCAN3 | Q9UKA8 | 307 |
| OR8B8 | HABP4 | Q5JVS0 | 301 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| OR8B8 | YLPM1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (3): PBRM1 (Affinity Capture-MS), YLPM1 (Affinity Capture-MS), BRD7 (Affinity Capture-MS)
ESM2 similar proteins: A6NCV1, A6NF89, A6NJZ3, A6NL08, A6NM76, O76000, O95007, O95221, P0C626, P0C629, P30955, P37070, P70526, Q15617, Q15620, Q60882, Q60893, Q60895, Q6IEU7, Q8N0Y5, Q8N162, Q8NGE1, Q8NGG4, Q8NGG8, Q8NGH3, Q8NGL1, Q8NGP8, Q8NGP9, Q8NGR5, Q8NGR8, Q8NGS4, Q8NGT1, Q8NGX3, Q8NH01, Q8VEW5, Q8VF66, Q8VF76, Q8VFD0, Q8VFD3, Q8VFK2
Diamond homologs: A6NDH6, A6NET4, A6NHG9, A6NKK0, A6NL26, A6NMS3, O95221, P0C626, P0C628, P0C7N1, P0C7N5, P0DMU2, P0DN80, P34985, P37068, P37070, P37071, P37072, Q13606, Q15617, Q15620, Q60880, Q60882, Q60884, Q60886, Q60893, Q60894, Q6UXT6, Q7TS48, Q8N127, Q8N146, Q8N162, Q8NG75, Q8NG78, Q8NGC0, Q8NGF4, Q8NGF7, Q8NGG0, Q8NGG1, Q8NGG2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
42 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 39 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
178 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:124440983:AGAAG:A | donor_gain | 0.9800 |
| 11:124441021:C:CA | donor_gain | 0.9800 |
| 11:124440941:T:C | donor_gain | 0.9600 |
| 11:124441036:AAG:A | donor_gain | 0.9000 |
| 11:124441022:C:A | donor_gain | 0.8500 |
| 11:124440977:C:CT | donor_gain | 0.7700 |
| 11:124440680:TGGTG:T | donor_gain | 0.7400 |
| 11:124440798:C:CA | donor_gain | 0.6900 |
| 11:124440415:C:CC | acceptor_gain | 0.6500 |
| 11:124440795:ACAC:A | donor_gain | 0.6400 |
| 11:124440796:CACC:C | donor_gain | 0.6400 |
| 11:124440379:TTGG:T | donor_gain | 0.6100 |
| 11:124440913:G:C | donor_gain | 0.6000 |
| 11:124440968:C:CT | donor_gain | 0.6000 |
| 11:124440413:TG:T | acceptor_gain | 0.5800 |
| 11:124440940:A:AC | donor_gain | 0.5800 |
| 11:124440963:C:A | donor_gain | 0.5700 |
| 11:124440969:CACAG:C | donor_gain | 0.5700 |
| 11:124440912:A:AC | donor_gain | 0.5300 |
| 11:124440940:AT:A | donor_gain | 0.5000 |
| 11:124440965:C:T | donor_gain | 0.5000 |
| 11:124440970:A:T | donor_gain | 0.4900 |
| 11:124440410:AGATG:A | acceptor_loss | 0.4800 |
| 11:124440413:TGCT:T | acceptor_loss | 0.4800 |
| 11:124440414:GCTGG:G | acceptor_loss | 0.4800 |
| 11:124440415:C:G | acceptor_loss | 0.4800 |
| 11:124440416:T:A | acceptor_loss | 0.4800 |
| 11:124440664:CACA:C | donor_loss | 0.4800 |
| 11:124440665:ACACC:A | donor_loss | 0.4800 |
| 11:124440666:CA:C | donor_loss | 0.4800 |
AlphaMissense
2072 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:124440213:G:C | S291R | 0.903 |
| 11:124440213:G:T | S291R | 0.903 |
| 11:124440215:T:G | S291R | 0.903 |
| 11:124440721:C:G | R122P | 0.903 |
| 11:124441050:A:C | F12L | 0.902 |
| 11:124441050:A:T | F12L | 0.902 |
| 11:124441052:A:G | F12L | 0.902 |
| 11:124440861:A:C | S75R | 0.887 |
| 11:124440861:A:T | S75R | 0.887 |
| 11:124440863:T:G | S75R | 0.887 |
| 11:124440732:C:A | M118I | 0.882 |
| 11:124440732:C:G | M118I | 0.882 |
| 11:124440732:C:T | M118I | 0.882 |
| 11:124440582:G:C | F168L | 0.881 |
| 11:124440582:G:T | F168L | 0.881 |
| 11:124440584:A:G | F168L | 0.881 |
| 11:124440330:A:C | F252L | 0.855 |
| 11:124440330:A:T | F252L | 0.855 |
| 11:124440332:A:G | F252L | 0.855 |
| 11:124440730:G:T | A119E | 0.855 |
| 11:124440378:T:A | K236N | 0.845 |
| 11:124440378:T:G | K236N | 0.845 |
| 11:124440360:G:C | S242R | 0.841 |
| 11:124440360:G:T | S242R | 0.841 |
| 11:124440362:T:G | S242R | 0.841 |
| 11:124440960:G:C | N42K | 0.825 |
| 11:124440960:G:T | N42K | 0.825 |
| 11:124440228:G:C | N286K | 0.822 |
| 11:124440228:G:T | N286K | 0.822 |
| 11:124440723:G:C | D121E | 0.822 |
dbSNP variants (sampled 300 via entrez): RS1000082699 (11:124446195 T>C), RS1000497890 (11:124439943 C>T), RS1000810891 (11:124439880 C>T), RS1000946071 (11:124440154 G>A,C,T), RS1001279964 (11:124438783 A>G), RS1002080262 (11:124443382 T>A,G), RS1002153561 (11:124444594 C>T), RS1002166829 (11:124438328 CT>C), RS1002278766 (11:124438991 G>A), RS1002441320 (11:124443199 G>A), RS1002556980 (11:124437407 C>G,T), RS1002856525 (11:124437400 T>C), RS1003018797 (11:124437647 TGTGTGTGTGTGTGTGTGTGTGC>T), RS1003020212 (11:124443298 A>C), RS1003403102 (11:124437645 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010796_2653 | Electrocardiogram morphology (amplitude at temporal datapoints) | 4.000000e-08 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004327 | electrocardiography |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | affects cotreatment, decreases expression | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Azacitidine | increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Dexamethasone | affects cotreatment, decreases expression | 1 |
| Bucladesine | affects cotreatment, increases expression | 1 |
| Estradiol | affects cotreatment, increases expression | 1 |
| Folic Acid | decreases expression | 1 |
| Indomethacin | affects cotreatment, decreases expression | 1 |
| Methapyrilene | increases methylation | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| 1-Methyl-3-isobutylxanthine | affects cotreatment, decreases expression | 1 |
| Medroxyprogesterone Acetate | affects cotreatment, increases expression | 1 |
| Asbestos, Crocidolite | affects expression | 1 |
| Cadmium Chloride | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.